in Newswire June 23, 2020

Chembio Diagnostics Hit with Class Action After FDA Pulls Emergency Use Permission For COVID-19 Antibody Test

by Corrado Rizzi

Last Updated on June 23, 2020

Chernysh v. Chembio Diagnostics, Inc. et al.

Filed: June 18, 2020 § 2:20-cv-02706

Chembio Diagnostics faces a class action centered on the FDA's revocation of an emergency use authorization for the company's COVID-19 antibody test.

State(s)

New York

Last Updated on June 23, 2020 — 9:06 AM

Corrado Rizzi

corrado@classaction.org

Corrado Rizzi is the Managing Editor and a writer for ClassAction.org.

About ClassAction.org

ClassAction.org is a group of online professionals (designers, developers and writers) with years of experience in the legal industry.

Learn More

Before commenting, please review our comment policy.